MIM
Monashee Investment Management Portfolio holdings
AUM
$190M
This Quarter Return
-6.14%
1 Year Return
+42.84%
3 Year Return
+185.9%
5 Year Return
+237.5%
10 Year Return
+2,730.86%
AUM
$345M
AUM Growth
+$345M
(-15%)
Cap. Flow
-$18M
Cap. Flow
% of AUM
-5.22%
Top 10 Holdings %
Top 10 Hldgs %
88.57%
Holding
63
New
19
Increased
2
Reduced
15
Closed
26
Top Buys
| 1 |
Vanguard Total Stock Market ETF
VTI
|
$27.2M |
| 2 |
AN2 Therapeutics
ANTX
|
$6.53M |
| 3 |
SolarEdge
SEDG
|
$6.45M |
| 4 |
Southwest Gas
SWX
|
$5.87M |
| 5 |
Piedmont Lithium
PLL
|
$2.92M |
Top Sells
| 1 |
Agree Realty
ADC
|
$8.92M |
| 2 |
Foghorn Therapeutics
FHTX
|
$5.49M |
| 3 |
Natera
NTRA
|
$5.14M |
| 4 |
SoFi Technologies
SOFI
|
$4.74M |
| 5 |
Wheels Up
UP
|
$4.28M |
Sector Composition
| 1 | Healthcare | 16.01% |
| 2 | Utilities | 2.9% |
| 3 | Technology | 1.92% |
| 4 | Materials | 1.65% |
| 5 | Communication Services | 0.98% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Vanguard Total Stock Market ETF
VTI
$526B
| $259M | 75.03% | 1,137,100 +119,400 | +12% | +$27.2M |
|
|
2
AN2 Therapeutics
ANTX
$30.1M
| $6.53M | 1.89% | +433,330 | New | +$6.53M |
|
|
3
SolarEdge
SEDG
$2.01B
| $6.45M | 1.87% | +20,000 | New | +$6.45M |
|
4
Hyperfine
HYPR
$97.4M
| $6.21M | 1.8% | 1,755,038 -416,357 | -19% | -$1.47M |
|
|
5
Southwest Gas
SWX
$5.75B
| $5.87M | 1.7% | +75,000 | New | +$5.87M |
|
6
Fulcrum Therapeutics
FULC
$351M
| $5.6M | 1.62% | 236,991 -36,054 | -13% | -$852K |
|
7
Caribou Biosciences
CRBU
$174M
| $4.32M | 1.25% | 470,000 -34,377 | -7% | -$316K |
|
|
SLGC
8
DELISTED
SomaLogic, Inc. Class A Common Stock
SLGC
| $4.09M | 1.18% | 510,000 -320,000 | -39% | -$2.57M |
|
9
KalVista Pharmaceuticals
KALV
$678M
| $3.89M | 1.13% | 264,111 -35,889 | -12% | -$529K |
|
10
DocGo
DCGO
$153M
| $3.79M | 1.1% | 409,431 -340,569 | -45% | -$3.15M |
|
11
PLAYSTUDIOS Inc
MYPS
$121M
| $3.39M | 0.98% | 699,503 -300,497 | -30% | -$1.45M |
|
|
12
Piedmont Lithium
PLL
$159M
| $2.92M | 0.85% | +40,000 | New | +$2.92M |
|
|
LFG
13
DELISTED
Archaea Energy Inc.
LFG
| $2.85M | 0.83% | +130,000 | New | +$2.85M |
|
|
VIEW
14
DELISTED
View, Inc. Class A Common Stock
VIEW
| $2.76M | 0.8% | 1,500,000 | – | – |
|
15
Dyne Therapeutics
DYN
$1.92B
| $2.7M | 0.78% | 279,704 +184,404 | +193% | +$1.78M |
|
16
Travere Therapeutics
TVTX
$1.56B
| $2.58M | 0.75% | +100,000 | New | +$2.58M |
|
|
NARI
17
DELISTED
Inari Medical, Inc. Common Stock
NARI
| $2.27M | 0.66% | +25,000 | New | +$2.27M |
|
18
Albertsons Companies
ACI
$10.9B
| $2M | 0.58% | +60,000 | New | +$2M |
|
|
CLYM
19
Climb Bio, Inc. Common Stock
CLYM
$151M
| $1.91M | 0.55% | 227,201 -72,799 | -24% | -$611K |
|
20
Hess Midstream
HESM
$5.4B
| $1.8M | 0.52% | +60,000 | New | +$1.8M |
|
21
Compass Therapeutics
CMPX
$483M
| $1.74M | 0.5% | 1,270,211 -729,789 | -36% | -$1,000K |
|
|
KDNY
22
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
| $1.47M | 0.43% | 90,000 -5,000 | -5% | -$81.8K |
|
23
Athira Pharma
ATHA
$15.3M
| $1.35M | 0.39% | +100,000 | New | +$1.35M |
|
24
Northwest Natural Holdings
NWN
$1.7B
| $1.29M | 0.37% | +25,000 | New | +$1.29M |
|
25
Apellis Pharmaceuticals
APLS
$3.48B
| $1.25M | 0.36% | +24,555 | New | +$1.25M |
|